ECG Telemetry Devices Market Report by Product (Event Monitoring and MCT (Mobile Cardiac Telemetry), and Others), Application (Arrhythmias, Myocardial Ischemia and Infarction, Pacemaker Monitoring, and Others), End User (Hospitals, Home Healthcare), and Region 2025-2033

ECG Telemetry Devices Market Report by Product (Event Monitoring and MCT (Mobile Cardiac Telemetry), and Others), Application (Arrhythmias, Myocardial Ischemia and Infarction, Pacemaker Monitoring, and Others), End User (Hospitals, Home Healthcare), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5942

Market Overview:

The global ECG telemetry devices market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.93% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 6.1 Billion
Market Forecast in 2033
USD 11.2 Billion
Market Growth Rate (2025-2033) 6.93%


Electrocardiography (ECG) telemetry devices enable rapid ECG monitoring of patients with suspected cardiovascular diseases (CVDs). They help detect electrical impulses generated by cardiac tissues, which are subsequently translated into waveforms. They find extensive applications in hospitals and home healthcare services. At present, the increasing prevalence of CVDs, such as heart attacks and strokes, due to alcohol and tobacco consumption, obesity, and physical inactivity among individuals is catalyzing the demand for ECG telemetry devices across the globe.

ECG Telemetry Devices Market Trends:

ECG telemetry devices are used in the diagnosis and treatment of arrhythmia wherein the heart rate of an individual becomes abnormal. These devices offer information about fluctuations in the rhythm of the heart that allows doctors to take required actions. Apart from this, ECG telemetry devices comprise resting ECGs, which are utilized for identifying conditions, such as coronary artery disease (CAD) or congestive heart failure (CHF). This, along with the thriving healthcare industry, is strengthening the growth of the market. Besides this, there is a significant rise in the utilization of health monitoring devices like electrocardiographs, digital thermometers, automatic blood pressure monitors, blood glucose monitors, and body fat monitors in the residential sector. They can be operated by patients or their caretakers with minimal training. Furthermore, coronavirus disease (COVID-19) affects the cardiovascular system and leads to myocardial damage and cardiac and endothelial dysfunction. This, coupled with the increasing geriatric population, is propelling the demand for ECG telemetry devices around the world. Other factors, including rising technological advancements and the growing awareness about cardiovascular health among the masses, are projected to influencing the overall sales and profitability positively in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global ECG telemetry devices market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

  • Event Monitoring and MCT (Mobile Cardiac Telemetry)
  • Others
     

Breakup by Application:

  • Arrhythmias
  • Myocardial Ischemia and Infarction
  • Pacemaker Monitoring
  • Others
     

Breakup by End User:

  • Hospitals
  • Home Healthcare
     

Breakup by Region:

ECG Telemetry Devices Market By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and ZOLL Medical Corporation (Asahi Kasei Corporation).

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Product, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and ZOLL Medical Corporation (Asahi Kasei Corporation)
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global ECG telemetry devices market was valued at USD 6.1 Billion in 2024.

We expect the global ECG telemetry devices market to exhibit a CAGR of 6.93% during 2025-2033.

The sudden outbreak of the COVID-19 pandemic has led the increasing requirement for ECG telemetry devices to monitor the coronavirus-infected patients, as it affects the cardiovascular system and can cause myocardial damage as well as cardiac and endothelial dysfunction.

The rising prevalence of CVDs, such as heart attacks and strokes, along with the growing adoption of ECG telemetry devices for diagnosing and treating arrhythmia, wherein the heart rate of an individual becomes abnormal, is primarily driving the global ECG telemetry devices market.

Based on the product, the global ECG telemetry devices market has been categorized into event monitoring and MCT (Mobile Cardiac Telemetry) and others. Currently, event monitoring and MCT (Mobile Cardiac Telemetry) accounts for the majority of the total market share.

Based on the application, the global ECG telemetry devices market can be segregated into arrhythmias, myocardial ischemia and infarction, pacemaker monitoring, and others. Among these, arrhythmias hold the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global ECG telemetry devices market include Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., and ZOLL Medical Corporation (Asahi Kasei Corporation).

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
ECG Telemetry Devices Market Report by Product (Event Monitoring and MCT (Mobile Cardiac Telemetry), and Others), Application (Arrhythmias, Myocardial Ischemia and Infarction, Pacemaker Monitoring, and Others), End User (Hospitals, Home Healthcare), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials